Information:
Error:
ID
22957
Description
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE); ODM derived from: https://clinicaltrials.gov/show/NCT00510952
Link
https://clinicaltrials.gov/show/NCT00510952
Keywords
Versions (1)
- 6/18/17 6/18/17 -
Uploaded on
June 18, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus, Type 2 NCT00510952
Eligibility Diabetes Mellitus, Type 2 NCT00510952
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00510952
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
have type 2 diabetes mellitus for at least 1 year.
boolean
C0011860 (UMLS CUI [1])
ID.2
Item
are greater than or equal to 18 years old.
boolean
C0001779 (UMLS CUI [1])
ID.3
Item
have been receiving oral antihyperglycemic medications (oams), without insulin, for at least 3 months immediately prior to the study and have been on stable doses of at least 2 of the following oams for the 6 weeks prior to visit 1: metformin-
boolean
C0087111 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
C0025598 (UMLS CUI [1,2])
ID.4
Item
sulfonylureas-dipeptidyl peptidase-iv (dpp-iv) inhibitors-thiazolidinediones (tzds)
boolean
C0087111 (UMLS CUI [1,1])
C3653359 (UMLS CUI [1,2])
C1257987 (UMLS CUI [1,3])
C3653359 (UMLS CUI [1,2])
C1257987 (UMLS CUI [1,3])
ID.5
Item
have a hemoglobin a1c (hba1c) greater than or equal to 7.5% and less than or equal to 10.0%, as measured by a central laboratory before visit 2.
boolean
C0019018 (UMLS CUI [1])
ID.6
Item
body mass index (bmi) greater than or equal to 25 and less than or equal to 45 kg/meter squared.
boolean
C1305855 (UMLS CUI [1])
ID.7
Item
have used insulin therapy (outside of pregnancy) any time in the past 2 years, except for short-term treatment of acute conditions, and up to a maximum of 4 weeks.
boolean
C0557978 (UMLS CUI [1])
ID.8
Item
have taken any glucose-lowering medications not included in inclusion criterion #3; (for example, acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide) in the past 3 months before visit 1.
boolean
C0087111 (UMLS CUI [1])
ID.9
Item
have had more than 1 episode of severe hypoglycemia, within 6 months prior to entry into the study, or is currently diagnosed as having hypoglycemia unawareness.
boolean
C0150254 (UMLS CUI [1])
ID.10
Item
have had 2 or more emergency room visits or hospitalizations due to poor glucose control in the past 6 months.
boolean
C0726398 (UMLS CUI [1,1])
C0019993 (UMLS CUI [1,2])
C2114437 (UMLS CUI [1,3])
C0019993 (UMLS CUI [1,2])
C2114437 (UMLS CUI [1,3])
ID.11
Item
are pregnant or intend to become pregnant during the course of the study or are sexually active women of childbearing potential not actively practicing birth control by a method determined by the investigator to be medically acceptable.
boolean
C0032961 (UMLS CUI [1,1])
C0009862 (UMLS CUI [1,2])
C0009862 (UMLS CUI [1,2])